A solitary pulmonary nodule is a small, round spot on the lung that measures less than 3 centimeters (about 1.2 inches) in diameter. It shows up as a white shadow on a chest CT scan or X-ray, sits entirely within lung tissue, and isn’t connected to the chest wall or accompanied by swollen lymph nodes. These nodules are remarkably common: roughly 30% of all chest CT scans reveal at least one. The vast majority turn out to be harmless, but because a small percentage represent early-stage lung cancer, every nodule needs a careful evaluation.
How Nodules Are Found
Most solitary pulmonary nodules are discovered by accident. You go in for a CT scan after a car accident, before surgery, or because of an unrelated chest complaint, and the radiologist spots a small round opacity in your lung. Lung cancer screening programs using low-dose CT scans are another common source. In either case, the nodule itself causes no symptoms. It doesn’t make you cough, hurt, or feel short of breath. That’s why these findings often catch people off guard.
Anything 3 centimeters or larger is no longer classified as a nodule. It’s called a lung mass, and the approach to evaluating it changes significantly because larger lesions carry a higher probability of cancer.
What Causes Them
The list of possible causes is long, but it helps to think of nodules in two broad categories: benign and malignant.
Benign nodules account for the majority of findings. The most common type is a granuloma, a tiny clump of immune cells that forms when your body walls off an old infection from organisms like tuberculosis or certain fungi. Hamartomas, which are small clusters of normal tissue (cartilage, fat, connective tissue) that grew in a slightly disorganized way, are the most common benign lung tumor. Scarring from a past pneumonia, a small area of inflammation, or even a lymph node sitting within the lung tissue can also appear as a solitary nodule.
Malignant nodules are less common overall but represent the reason every nodule gets taken seriously. A nodule can be an early primary lung cancer, or less frequently, a metastasis from a cancer somewhere else in the body. The challenge is that on a single scan, benign and malignant nodules can look very similar.
Features That Raise or Lower Concern
Radiologists look at several characteristics to estimate the likelihood that a nodule is cancerous. Size is the most straightforward: nodules under 6 millimeters carry very low risk, while those approaching 3 centimeters warrant closer scrutiny. Shape matters too. Spiculation, where the edges of the nodule look jagged or starburst-like rather than smooth, appeared in 60% of malignant nodules in one large study compared to just 15% of benign ones.
Calcification patterns also provide clues. Certain types of dense calcium deposits, such as a uniform central core or concentric rings, are strong indicators that a nodule is benign, typically a healed granuloma. Irregular or eccentric calcification is less reassuring.
Nodules aren’t all the same density, either. Some are solid throughout, some appear as faint, hazy patches called ground-glass nodules, and some are a mix of both (part-solid). Part-solid nodules with a growing solid component tend to be watched especially carefully.
Your personal risk factors weigh heavily in the overall assessment. A history of smoking, older age, prior cancer, or a family history of lung cancer all shift the probability upward. A 35-year-old nonsmoker with a smooth, small nodule is in a vastly different risk category than a 65-year-old with a 30-pack-year smoking history and a spiculated lesion.
How Growth Rate Helps Tell the Difference
One of the most reliable ways to distinguish a benign nodule from a malignant one is to watch whether it grows, and how fast. Radiologists measure this using volume doubling time: how many days it takes a nodule to double in volume. Because nodules are three-dimensional, even a small increase in diameter represents a meaningful jump in volume.
Malignant solid nodules tend to double in volume in about 200 days on average, while benign ones that do grow take closer to 400 days. In screening studies, 92% of cancerous solid nodules had a doubling time under 400 days. A nodule with a doubling time over 600 days is more likely benign, though rare exceptions exist on both sides. Some benign nodules grow quickly (due to active infection, for example), and an occasional cancer grows very slowly. That’s why growth rate is one piece of the puzzle rather than the whole answer.
A nodule that hasn’t changed at all over two years of monitoring is generally considered benign, and follow-up can be stopped.
What Happens After a Nodule Is Found
The next steps depend almost entirely on the nodule’s size, appearance, and your personal risk profile.
- Very small nodules (under 6 mm): If you have no major risk factors, these often require nothing more than a routine follow-up CT scan in about 12 months to confirm stability. Many don’t need any follow-up at all.
- Intermediate nodules (6 to 10 mm): These are typically monitored with a series of CT scans over one to two years. Smokers and others with higher risk may be scanned more frequently, at intervals of 3, 6, 12, 18, and 24 months. Nonsmokers might follow a less intensive schedule at 6, 12, and 24 months. If the nodule grows by 2 millimeters or more, further workup is recommended.
- Larger nodules (10 mm and above): Solid nodules at this size generally trigger a more definitive evaluation, which may include advanced imaging or a biopsy.
PET Scans and Biopsies
When a nodule looks suspicious but isn’t clearly cancerous on CT, a PET scan is often the next step. This imaging test detects areas of high metabolic activity, since cancer cells burn through sugar faster than normal tissue. For pulmonary nodules, PET scans have a sensitivity around 94% and a specificity around 83%, meaning they’re good at catching cancers but can occasionally light up for non-cancerous causes like active infections or inflammation. For very small nodules under 1 centimeter, accuracy drops somewhat, though one study still reported 93% sensitivity at that size.
If imaging remains inconclusive and the suspicion of cancer is moderate to high, a tissue sample (biopsy) becomes necessary. The most common approach is a needle biopsy performed through the chest wall, guided by CT imaging. This is typically done as an outpatient procedure. For nodules located near the center of the lung close to the airways, a bronchoscopy, where a thin camera is guided down through the throat into the airways, can sometimes reach the nodule. However, for nodules smaller than 2 centimeters, the needle-through-the-chest-wall approach tends to be more accurate at obtaining a usable tissue sample.
When a Nodule Needs to Be Removed
Surgery is considered when a biopsy confirms cancer or when imaging strongly suggests malignancy. The good news is that lung cancers caught at the nodule stage, before they’ve spread, have significantly better outcomes than those found later. Removing a small, early-stage lung cancer can be curative.
Surgery is also sometimes chosen when repeated monitoring leaves a nodule in an ambiguous zone: not clearly benign, not clearly malignant, and not accessible for a reliable biopsy. In these cases, a surgeon can remove the nodule and have it examined under a microscope, simultaneously providing a diagnosis and treatment if it turns out to be cancer.
For nodules that are confidently benign based on their imaging features, stability over time, or biopsy results, no treatment is needed. They simply stay in your lung without causing problems.